SCHEMBL7013399

SCHEMBL7013399

NS(=O)(=O)c1[c]nc2ccccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 7/20 0.43
CA1 P00915 4/20 0.43
CA9 Q16790 3/20 0.43
CA12 O43570 2/20 0.43
LMNA P02545 1/20 0.39
ALDH1A1 P00352 5/20 0.39
HPGD P15428 2/20 0.39
GLA P06280 1/20 0.39
MAPT P10636 1/20 0.39
ACHE P22303 1/20 0.39
CA4 P22748 1/20 0.39
CA7 P43166 1/20 0.39
CA14 Q9ULX7 1/20 0.39
KDM4E B2RXH2 4/20 0.38
CYP1A2 P05177 1/20 0.37
SCN10A Q9Y5Y9 2/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL641339 0.71 ALDH1A1 (0.47) LMNAALDH1A1HPGDGLAMAPT
SCHEMBL3340171 0.70 ALDH1A1 (0.41) CA2CA1CA9CA12LMNA
Acridine SCHEMBL2140243 0.70 ALDH1A1 (0.71) CA2CA1CA9CA12LMNA
SCHEMBL1998020 0.68 LMNA (0.47) CA2CA1CA9CA12LMNA
SCHEMBL5749007 0.68 IKBKB (0.49) ALDH1A1HPGDGLAMAPTACHE
SCHEMBL521935 0.67 NQO2 (0.46) ALDH1A1HPGDGLAMAPTACHE
SCHEMBL558480 0.67 ALDH1A1 (0.46) LMNAALDH1A1HPGDGLAMAPT
SCHEMBL7060124 0.67 ALDH1A1 (0.46) LMNAALDH1A1HPGDGLAMAPT
SCHEMBL584784 0.67 ALDH1A1 (0.46) LMNAALDH1A1HPGDGLAMAPT
SCHEMBL269884 0.67 ALDH1A1 (0.46) LMNAALDH1A1HPGDGLAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6670447-B2 An 3-acyl-4-substituted-oxazolidin-2,5-dione that readily reacts with nucleophilic reagents such as free amino acids; use in peptide synthesis for example MITSUI CHEMICALS, INC. (JP) 2003-12-30 US disclosed
EP-1298127-A1 AMINO ACID-N-CARBOXY ANHYDRIDES HVAING SUBSTITUENT AT NITROGEN Mitsui Chemicals, Inc. (JP) 2003-04-02 EP disclosed
US-20020173664-A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen MITSUI CHEMICALS, INC. (JP) 2002-11-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173664-A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen DNPEP, HDGF, ANPEP CA2 24/4885CA1 15/4885CA9 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.